Procter & Gamble Health Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: PGHL BSE: 500126 BSE: 533081

About Procter & Gamble Health Limited

No company profile on record yet.

Key facts

BSE symbol500126
BSE symbol533081
NSE symbolPGHL
ISININE199A01012
CINL99999MH1967PLC013726
Listing date24 Apr 1996
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorDholakia & Associates LLP (Nrupang B Dholakia)
Registered officeP & G Plazza, Cardinal Gracias Road, Chakala, Andheri East Mumbai-400099
Registrar & transfer agentKFin Technologies Limited Selenium, Tower B, Plot No-31 & 32, Financial District, Nanakramguda, Serilingampally Hyderabad Rangareddi TG 500032

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)1,425†—886†944†1,116†
Net profit327234184200185†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Milind ThatteExecutive DirectorJune 30, 2026
Shashank SrowthyExecutive DirectorJune 30, 2026
Krishna SarmaIndependent DirectorJune 30, 2026
Sharad TyagiIndependent DirectorJune 30, 2026
Subramanian MadhavanIndependent DirectorJune 30, 2026
Aalok AgrawalNon-Executive DirectorJune 30, 2026
Seema SambasivanNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.